Ullman Comments About Risk to NAC Retailers

May 17, 2021 | Compliance Investigations & White Collar

Marc Ullman was quoted in the Natural Products Insider article, “Stakeholders can’t sue FDA over NAC warning letters.”

A recent court decision prevents stakeholders from suing the FDA based merely on its positions asserted in warning letters. The article discusses how a lingering dispute between the agency and the dietary supplement industry regarding NAC (N-acetyl-L-cysteine) will be affected by this decision.

Retailers of the supplement should be concerned, according to Ullman.

Read the full article. 

Share this article:

Related News

Get legal updates and news delivered to your inbox